AlphaFold predicted structure
STX4 · Q12846

Mean pLDDT
78.1/ 100
Confident
297 residues
Confidence breakdown
- Very high(≥ 90)39%
- Confident(70–90)31%
- Low(50–70)19%
- Very low(< 50)12%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
syntaxin 4
Annotations refreshed 1 month ago.
Moderate Evidence (Amber)
Monogenic hearing loss
BIALLELIC, autosomal or pseudoautosomalhearing loss, autosomal recessive 123
neurodegenerative disease
Sensorineural hearing impairment
ovarian carcinoma
hearing loss disorder
Hearing impairment
acute myeloid leukemia
urinary bladder carcinoma
colorectal carcinoma
gastric carcinoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Syntaxin-4
Plasma membrane t-SNARE that mediates docking of transport vesicles (By similarity). Necessary for the translocation of SLC2A4 from intracellular vesicles to the plasma membrane (By similarity). In neurons, recruited at neurite tips to membrane domains rich in the phospholipid 1-oleoyl-2-palmitoyl-PC (OPPC) which promotes neurite tip surface expression of the dopamine transporter SLC6A3/DAT by facilitating fusion of SLC6A3-containing transport vesicles with the plasma membrane (By similarity). Together with STXB3 and VAMP2, may also play a role in docking/fusion of intracellular GLUT4-containing vesicles with the cell surface in adipocytes and in docking of synaptic vesicles at presynaptic active zones (By similarity). Required for normal hearing (PubMed:36355422)
STX4 · Q12846

Mean pLDDT
78.1/ 100
Confident
297 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0